[{"address1": "10578 Science Center Drive", "address2": "Suite 125", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 401 7900", "website": "https://www.aviditybiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 391, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Co-Founder & Independent Chairman", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 71908, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Boyce", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1270910, "exercisedValue": 19471016, "unexercisedValue": 23394110}, {"maxAge": 1, "name": "Dr. W. Michael F. Flanagan Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 855110, "exercisedValue": 3168572, "unexercisedValue": 2408225}, {"maxAge": 1, "name": "Mr. John B. Moriarty Jr., ESQ., J.D.", "age": 56, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 683588, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa  McCarthy", "age": 60, "title": "Chief Human Resources Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 782410, "exercisedValue": 2661178, "unexercisedValue": 2015118}, {"maxAge": 1, "name": "Prof. Mark E. Davis Ph.D.", "title": "Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank P. McCormick Ph.D.", "age": 74, "title": "Scientific Founder & Member of Scientific Advisory Board", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles  Calderaro III", "age": 60, "title": "Chief Technical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric B. Mosbrooker", "age": 57, "title": "Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen P. Gallagher", "age": 43, "title": "Chief Program Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 44.18, "open": 44.63, "dayLow": 44.28, "dayHigh": 47.26, "regularMarketPreviousClose": 44.18, "regularMarketOpen": 44.63, "regularMarketDayLow": 44.28, "regularMarketDayHigh": 47.26, "payoutRatio": 0.0, "beta": 0.966, "forwardPE": -15.511551, "volume": 1422939, "regularMarketVolume": 1422939, "averageVolume": 3366257, "averageVolume10days": 2060800, "averageDailyVolume10Day": 2060800, "bid": 33.77, "ask": 56.92, "bidSize": 2, "askSize": 2, "marketCap": 6857457152, "fiftyTwoWeekLow": 21.51, "fiftyTwoWeekHigh": 56.0, "allTimeHigh": 56.0, "allTimeLow": 4.825, "priceToSalesTrailing12Months": 639.15155, "fiftyDayAverage": 43.6184, "twoHundredDayAverage": 33.901325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4868697600, "profitMargins": 0.0, "floatShares": 107830794, "sharesOutstanding": 145903337, "sharesShort": 22242546, "sharesShortPriorMonth": 15671917, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.1524, "heldPercentInsiders": 0.04526, "heldPercentInstitutions": 1.01696, "shortRatio": 6.11, "shortPercentOfFloat": 0.15359999, "impliedSharesOutstanding": 145903337, "bookValue": 9.875, "priceToBook": 4.759494, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -455742016, "trailingEps": -3.56, "forwardEps": -3.03, "enterpriseToRevenue": 453.789, "enterpriseToEbitda": -9.386, "52WeekChange": 0.06939709, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 47.0, "targetHighPrice": 96.0, "targetLowPrice": 52.0, "targetMeanPrice": 68.11111, "targetMedianPrice": 65.0, "recommendationMean": 1.27778, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 18, "totalCash": 1183143936, "totalCashPerShare": 9.196, "ebitda": -518735008, "totalDebt": 5135000, "quickRatio": 8.823, "currentRatio": 9.259, "totalRevenue": 10729000, "debtToEquity": 0.431, "revenuePerShare": 0.084, "returnOnAssets": -0.24011, "returnOnEquity": -0.37763, "grossProfits": -399707008, "freeCashflow": -259114752, "operatingCashflow": -489980992, "revenueGrowth": 0.881, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -44.48713, "financialCurrency": "USD", "symbol": "RNA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 6.38298, "regularMarketPrice": 47.0, "shortName": "Avidity Biosciences, Inc.", "exchange": "NGM", "messageBoardId": "finmb_257084190", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1759535815, "regularMarketTime": 1759521600, "longName": "Avidity Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591968600000, "postMarketChangePercent": 2.76596, "postMarketPrice": 48.3, "postMarketChange": 1.3, "regularMarketChange": 2.82, "regularMarketDayRange": "44.28 - 47.26", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3366257, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 25.49, "fiftyTwoWeekLowChangePercent": 1.1850302, "fiftyTwoWeekRange": "21.51 - 56.0", "fiftyTwoWeekHighChange": -9.0, "fiftyTwoWeekHighChangePercent": -0.16071428, "fiftyTwoWeekChangePercent": 6.939709, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.56, "epsForward": -3.03, "epsCurrentYear": -4.48603, "priceEpsCurrentYear": -10.47697, "fiftyDayAverageChange": 3.3815994, "fiftyDayAverageChangePercent": 0.077526905, "twoHundredDayAverageChange": 13.098675, "twoHundredDayAverageChangePercent": 0.38637647, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-12", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Avidity Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]